Evidence map›Paper›PMID 40291645›Full record

ArticlebioRxiv : the preprint server for biology2025

Context-dependent Interactors Regulate TDP-43 Dysfunction in ALS/FTLD.

Longxin Xie, Yuehua Zhu, Bryan T Hurtle, Matthew Wright, John L Robinson, Jocelyn C Mauna, Emily E Brown, Marilyn Ngo, Cristian A Bergmann, Jiazhen Xu and 9 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Longxin XieDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Yuehua ZhuDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Bryan T HurtleDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Matthew WrightThe Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University,, Chicago, IL, USA.
John L RobinsonCenter for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jocelyn C MaunaDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Emily E BrownDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Marilyn NgoDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Cristian A BergmannDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Jiazhen XuDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Jessica MerjaneDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Amanda M GleixnerDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Gabriela GrigoreanDepartment of Proteomics, University of California, Davis, CA, USA.
Feilin LiuDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Wilfried RossollDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Edward B LeeCenter for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Evangelos KiskinisThe Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University,, Chicago, IL, USA.
Maria ChikinaDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Christopher J DonnellyDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0002-2383-9015

Funding

Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Understanding Environmental Contributions to Heterogeneity in bvFTD.P01AG066597 · NIA · UNIVERSITY OF PENNSYLVANIA · PI David John Irwin, Corey T McMillan · 2020 to 2026
$18.8M
PAGES: Physical Activity Genomics, Epigenomics/transcriptomics SiteU24DK112331 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI STUART C. SEALFON, Martin John Walsh · 2017 to 2026
$18.5M
Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MNDR01NS127187 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BELZIL, VERONIQUE, DONNELLY, CHRISTOPHER JAMES · 2021 to 2025
$9.1M
Dissecting neuron-microglia-astrocyte interaction in AD pathogenesisRF1AG068581 · NIA · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PENG, JUNMIN, ROSSOLL, WILFRIED · 2020 to 2023
$5.4M
Title: Functional Annotation of Genomes via Phenotypic Convergence within Large Multi-species AlignmentsR01HG009299 · NHGRI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Maria D Chikina, Nathaniel L Clark · 2017 to 2026
$4.1M
Nuclear import receptors as modifiers of TDP-43 phase transition and toxicity in FTD/ALSR01AG077771 · NIA · MAYO CLINIC JACKSONVILLE · PI Wilfried Rossoll, James Shorter · 2023 to 2026
$2.8M
Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementiasRF1AG076122 · NIA · MAYO CLINIC JACKSONVILLE · PI ROSSOLL, WILFRIED · 2022 to 2023
$2.5M
Discovery and characterization of ocular regulatory elements through evolutionary analysisR01EY030546 · NEI · UNIVERSITY OF UTAH · PI CHIKINA, MARIA D, CLARK, NATHANIEL L · 2020 to 2024
$2.4M
Loss of VCP Function in Frontotemporal Lobar DegenerationRF1AG065341 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, EDWARD BYUNG-HA · 2022 to 2022
$2.4M
An optogenetic approach to establish the interplay between stress granules and TDP-43 proteinopathy in ALS/FTDR01NS105756 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONNELLY, CHRISTOPHER JAMES · 2018 to 2022
$1.8M
Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementiasR01AG076122 · NIA · MAYO CLINIC JACKSONVILLE · PI Wilfried Rossoll · 2025 to 2026
$1.5M
NEI NIH HHS R01 EY030546NHGRI NIH HHS R01 HG009299NIA NIH HHS P01 AG066597NIA NIH HHS P30 AG072979NIA NIH HHS R01 AG068581NIA NIH HHS R01 AG076122NIA NIH HHS R01 AG077771NIA NIH HHS R21 AG085314NIA NIH HHS RF1 AG065341NIA NIH HHS RF1 AG068581NIA NIH HHS RF1 AG076122NIDDK NIH HHS U24 DK112331NINDS NIH HHS R01 NS105756NINDS NIH HHS R01 NS127187NINDS NIH HHS R21 NS133676NINDS NIH HHS R21 NS141767
6 · The paper itself

Abstract

TDP-43 mislocalization, aggregation, and loss of splicing function are neuropathological hallmarks in over 97% of Amyotrophic Lateral Sclerosis (ALS), 45% of Frontotemporal Lobar Degeneration (FTLD), and 60% of Alzheimer's Disease, which has been reclassified as LATE-NC. However, the mechanisms underlying TDP-43 dysfunction remain elusive. Here, we utilize APEX2-driven proximity labeling and mass spectrometry to characterize the context-dependent TDP-43 interactome in conditions of cytoplasmic mislocalization, impaired RNA-binding contributing to aggregation, and oxidative stress. We describe context-dependent interactors, including disrupted interactions with splicing-related proteins and altered biomolecular condensate (BMC) associations. By integrating ALS and FTLD snRNA-seq data, we uncover disease-relevant molecular alterations and validate our dataset through a functional screen that identifies key TDP-43 regulators. We demonstrate that disrupting nuclear speckle integrity, particularly through the downregulation of the splicing factor SRRM2, promotes TDP-43 mislocalization and loss of function. Additionally, we identify NUFIP2 as an interactor associated with mislocalization that sequesters TDP-43 into cytoplasmic aggregates and co-localizes with TDP-43 pathology in patient tissue. We also highlight HNRNPC as a potent TDP-43 splicing regulator, where precise modulation of TDP-43 or HNRNPC can rescue cryptic exon splicing. These findings provide mechanistic insights and potential therapeutic targets for TDP-43 dysfunction.

Identifiers

PMID40291645
PMCPMC12026901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.